Cheryl Watson is an experienced regulatory affairs professional specializing in CMC for biologics, with over 25 years in the biotechnology industry. Currently, Cheryl serves as the Executive Director of CMC Regulatory at Merck and previously held the role of Executive Director - Regulatory CMC-Biologics at Bristol Myers Squibb. Cheryl's career includes significant positions at Johnson & Johnson and Merck, where they focused on regulatory compliance for biotechnology products, vaccines, and cell therapies. Cheryl earned education in pharmacology from the University of Cincinnati College of Medicine and is committed to advocating for regulatory convergence to foster innovation and improve quality.
This person is not in the org chart
This person is not in any teams
This person is not in any offices